Misplaced Pages

Martin Dow

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Pakistani pharmaceutical company founded 1995

Martin Dow
Company typePrivate
IndustryPharmaceutical
Founded1995; 29 years ago (1995)
FounderMuhammad Jawed Akhai
HeadquartersKarachi, Pakistan
Area servedAsia, Middle East, Europe, Africa
ProductsADVIT-D, BUSCOPAN PLUS, CONCOR, GLUCOPHAGE, INFEXIN CAPS, KLARIBACT, MERCIP, NEUROBION, POLYBION, ROZANTO, SANGOBION, TIXOMER, VONOSPIRE, WINTOGENO
RevenueIncrease Rs. 5000 crore (US$170 million) (2021)
Number of employees1,000+
SubsidiariesMartin Dow Limited
Martin Dow Marker Ltd.
Martin Dow Specialities (Pvt.) Ltd.
Martin Dow Pharmaceuticals (France)
Websitemartindow.com

Martin Dow is a Pakistani multinational pharmaceutical company which is based in Karachi. It was founded in 1995 and has six manufacturing facilities in Pakistan and one in France.

History

Martin Dow was founded in 1995 and began operations in 2000 with a small manufacturing facility in Lahore.

In 2010, Martin Dow acquired the manufacturing facility and brands of Roche Pakistan.

In 2015, Martin Dow was recognized as a Global Growth Company by the World Economic Forum. In the same year, Martin Dow entered into an alliance with Biocodex S.A., a France-based pharmaceutical company.

In 2016, German Merck KGaA executed a binding contract to divest its shareholding in Pakistan to Martin Dow Ltd.

In 2016, in a €1.5 million deal, Martin Dow acquired the Laboratoires Salem (before 2010 Bristol-Myers Squibb) pharmaceutical manufacturing facility in Meymac, France. In March 2017, the French President Francois Hollande inaugurated Martin Dow Pharma's Meymac Plant in France. The plant of V2Pharm in Gien, France was also taken over by Martin Dow.

In 2020, Martin Dow was awarded for excellent performance in fire safety and protection by the Sindh local government minister.

Controversy

In 2016, the National Accountability Bureau (NAB) arrested two directors of Martin Dow because it wrongfully derived financial benefits on the basis of illegal price increase.

References

  1. "Martin Dow Limited" (PDF). The Pakistan Credit Rating Agency Limited. Retrieved 29 February 2024.
  2. "CORPORATE PROFILE". Martin Dow. Retrieved 31 December 2016.
  3. "Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016. Martin Dow was established in 1995 initially as a pharmaceutical marketing company in Karachi (Pakistan)
  4. "Martin Dow - Corporate Profile". Martin Dow.
  5. bhooto, bilawal (21 November 2016). "A strategic relationship". Dawn. Retrieved 31 December 2016. With the acquisition of Merck Pakistan, Martin Dow will have six manufacturing facilities in the country.
  6. Mettis, Global (29 March 2019). "Martin Dow Pakistan adds state of art manufacturing facility in France". Mettis Global Link. Retrieved 22 August 2024.
  7. Baig, Mariam Ali (23 April 2021). "Interview: Javed Ghulam Mohammad, Group MD & CEO, Martin Dow Group". Aurora Magazine.
  8. "Martin Dow - Company Profile". Business Recorder. 15 July 2012. Retrieved 28 December 2016.
  9. "List of Global Growth Company Members" (PDF). World Economic Forum. Retrieved 30 December 2016.
  10. "Treating illness: Martin Dow, Biocodex ink alliance". Express Tribune. 12 March 2015. Retrieved 2 January 2017.
  11. "German pharma giant divests interests". The Express Tribune. PPI. 8 November 2016. Retrieved 28 December 2016.
  12. "Merck divests its Pakistan stake to Martin Dow". Dawn. 8 November 2016. Retrieved 28 December 2016.
  13. "Martin Dow acquires Merck operations in Pakistan". The News International. 8 November 2016. Retrieved 28 December 2016.
  14. "Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016. A Pakistani Pharmaceutical company, Martin Dow has acquired a pharmaceutical manufacturing facility in Meymac, France. The facility was earlier owned by the renowned pharmaceutical firm Bristol-Myers Squibb.
  15. Mérigaud, Corinne (3 December 2015). "Laboratoires Salem repris par le pakistanais Martin Dow". L'Usine Nouvelle. Retrieved 30 December 2016.
  16. "French President to inaugurate Pakistani Pharma Plant in France". The Nation. Retrieved 3 January 2017.
  17. "Inauguration of Martin Dow plant by the French President (Meymac, 16 March 2017)". La France au Pakistan - Ambassade de France au Pakistan. Retrieved 1 April 2019.
  18. "L'ancien site de V2Pharm à Gien va être repris". La Republique. 1 July 2015. Retrieved 3 January 2017.
  19. "Sindh LG Minister Nasir Shah gives Fire Safety Awards to 43 companies". Daily Times. 22 December 2020. Retrieved 1 January 2021.
  20. "Drug business: NAB arrests 8 involved in mega corruption". The Express Tribune. 23 November 2016.
  21. "NAB arrests eight in drug price-hike cases". The Nation. 23 November 2016.
  22. "NAB arrests top bureaucrat in illegal drugs price hike case". Daily Times (Pakistan). 25 November 2016.
Categories: